Simplifying Global Compliance
FDA Signals Greater Use of Real-World Evidence
Clinical Trials Advisor
The FDA is committed to using real-world evidence in drug approvals and post-market evaluations, and forthcoming guidance will describe RWE and its potential for satisfying FDA’s pre- and post-market requirements.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing